Allred Capital Management, LLC Veracyte, Inc. Transaction History

Allred Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$32.94 - $56.62 $1,317 - $2,264	-40 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$44.47 - $81.38 $2,001 - $3,662	-45 Reduced 52.94%	40 $2,000
Q1 2020 Apr 17, 2020	SELL	$16.13 - $30.17 $80 - $150	-5 Reduced 5.56%	85 $2.07 Million
Q4 2019 Jan 13, 2020	BUY	$20.78 - $29.99 $1,870 - $2,699	90 New	90 $2,000

308

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.63B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Allred Capital Management, LLC with notifications on news.